Pharma Logistics IQ observes: The value of supply chain transparency
Have your say on how enhanced visibility of the supply chain leads to service excellence and operational efficiency in our exclusive survey alongside TransVoyantAdd bookmark
The Covid-19 pandemic has illustrated clear vulnerabilities in the pharma supply chain as leaders struggle to adapt in the face of disruption and changing demand patterns.
With many pharma companies, wholesale distributors, hospitals and pharmacies battling to overcome drug shortages, both with Covid-related and unrelated treatments, improving supply chain transparency is becoming a higher priority for many.
Lend your voice in Pharma Logistics IQ’s seven-minute survey to shed light on how the pharma industry can enhance its supply chain transparency solutions, grow in resiliency and better prioritize business planning for the future.
Your results will be featured in a report created in collaboration with TransVoyant that will be released later this year.